Literature DB >> 8281456

Co-distribution of protease nexin-1 and protease nexin-2 in brains of non-human primates.

S L Wagner1, W E Van Nostrand, A L Lau, J S Farrow, M Suzuki, R T Bartus, R Schuppek, A Nguyen, C W Cotman, D D Cunningham.   

Abstract

The protease nexins are protease inhibitors which regulate key blood coagulation proteases and which appear to be involved in certain physiological and pathological processes in the brain. Protease nexin-1 (PN-1), a potent inhibitor of thrombin, can regulate processes on cultured neurons and astrocytes. Protease nexin-2 (PN-2), a potent inhibitor of coagulation factor XIa, is identical to the secreted form of the Alzheimer's amyloid beta-protein precursor. In the present studies, PN-1 and PN-2 were analyzed in different tissues of monkey using monoclonal antibodies for either quantitative immunoblotting or specific [125I]protease-binding assays. PN-1 was detected only in brain. PN-2 was most abundant in brain, followed by testis and to a lesser extent kidney. Other tissues examined including spinal cord, heart, pancreas, spleen, liver, lung and muscle were essentially devoid of both PN-1 and PN-2. Within the brain, the levels of PN-1 and PN-2 were highest in the parietal cortex and lowest in the cerebellum and brainstem. The thalamus and striatum contained intermediate amounts of both proteins. Aged Cebus monkey cerebral cortical tissue contained slightly lower levels of PN-1 than did the middle-aged or young monkey tissue. The co-distribution of PN-1 and PN-2 in brain, their relative abundance in brain cortex, and previous studies on their functions suggest that in the brain they may participate in the regulation of blood coagulation and cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8281456     DOI: 10.1016/0006-8993(93)90567-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations.

Authors:  F Striggow; M Riek; J Breder; P Henrich-Noack; K G Reymann; G Reiser
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

Review 2.  Cellular consequences of thrombin-receptor activation.

Authors:  R J Grand; A S Turnell; P W Grabham
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

3.  Intracerebral hemorrhage and thrombin-induced alterations in cerebral microvessel matrix.

Authors:  Yu-Huan Gu; Brian T Hawkins; Yoshikane Izawa; Yoji Yoshikawa; James A Koziol; Gregory J Del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2022-05-05       Impact factor: 6.960

4.  Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.

Authors:  R Veerhuis; P van der Valk; I Janssen; S S Zhan; W E Van Nostrand; P Eikelenboom
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 5.  Hemostasis and alterations of the central nervous system.

Authors:  Gregory J del Zoppo; Yoshikane Izawa; Brian T Hawkins
Journal:  Semin Thromb Hemost       Date:  2013-10-28       Impact factor: 4.180

Review 6.  Emerging Roles of Protease-Activated Receptors (PARs) in the Modulation of Synaptic Transmission and Plasticity.

Authors:  Rachel Price; Nicola Biagio Mercuri; Ada Ledonne
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.